Summary: Routine real-time WGS surveillance identified previously unrecognized hospital outbreaks, reduced transmission, and demonstrated significant cost savings, supporting integration of genomic surveillance into standard infection prevention programs.
Real-Time Genomic Surveillance Saves Lives and is Cost Effective in the Hospital Setting
Why This Matters:
- Traditional infection surveillance methods often fail to detect cryptic transmission events, allowing outbreaks to expand before intervention.
- Real-time genomic surveillance enables earlier identification of transmission chains, improving outbreak control and reducing healthcare-associated infections (HAIs).
- Demonstrated economic return on investment (ROI) strengthens the case for adopting genomic surveillance as a routine infection prevention strategy.
- The integration of genomics into infection control workflows represents a paradigm shift toward data-driven healthcare epidemiology.
Key Findings: This study evaluated the Enhanced Detection System for Healthcare-associated Transmission (EDS-HAT), a real-time genomic surveillance program implemented at a Hospital site from November 2021 to October 2023, involving the use of routine weekly whole-genome sequencing (WGS) of hospital isolates.1 The authors reported:
- Substantial hidden transmission was detected:
- 3,921 clinical isolates were sequenced during the study period.
- 476 isolates (12.1%) clustered into 172 outbreaks, many of which would not have been detected using traditional epidemiologic methods.
- Outbreak cluster sizes ranged from 2 to 16 patients, demonstrating frequent small-scale transmission events.
- Genomic surveillance enabled targeted interventions: 61.3% of outbreak clusters had identifiable epidemiological links once genomic data revealed transmission. Following infection prevention interventions, 95.6% of outbreaks showed no further transmission along the identified pathway.
- Clinical impact was measurable: Modeling estimated that implementation of real-time genomic surveillance: prevented 62 healthcare-associated infections and approximately 4.8 deaths over the 2-year study period.
- Strong economic benefit estimated with modeling: Gross cost savings: $1,011,146, net cost savings: $695,706, and 3.2-fold return on investment.
- Operational feasibility: Weekly sequencing was successfully integrated into routine infection prevention workflows. Real-time genomic feedback enabled rapid response and containment of transmission pathways.
Bigger Picture: This study represents a maturing phase in clinical genomic epidemiology, moving from retrospective outbreak investigation to real-time operational surveillance. Historically, WGS has been used primarily for outbreak confirmation after detection. This work demonstrates its viability as a primary surveillance tool.
Several broader implications emerge:
- Hospitals are increasingly adopting WGS as a routine infection-control tool, much as molecular diagnostics transformed pathogen detection in prior decades.
- The detection of 172 outbreaks through routine surveillance suggests that many healthcare-associated infections originate from undetected transmission chains and not isolated events.
- Cost-effectiveness remains one of the largest barriers to the adoption of genomic surveillance. Demonstrating net financial savings alongside improved clinical outcomes significantly strengthens the case for implementation.
(Image Credit: iStock/JuSun)
